article thumbnail

Simplifying Medication Management Allows Nurses to Focus More on Patient

Omnicell

Standardizing an interoperability solution that supports information exchange creates better medication management practices for nurses and improved patient engagement. Before the integration, medication dispensing typically occurred without a conversation at the patient's bedside. Subscribe today.

article thumbnail

Transforming Drug Diversion Through Technology and Data

Omnicell

The Chief of Anesthesia is now aware of flaws in documentation and has an awareness of open transactions through enhanced data visibility. The Omnicell Blog is the leading source for pharmacy care, exploring emerging trends, successful best practices, and ideas and insights focused on the digital transformation of pharmacy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why Community Pharmacy Is the Future of Patient Care

Omnicell

Local pharmacists have always strived to be more than medication dispensers. Crucially, CareScheduler keeps patients and staff safe during the pandemic by minimizing the physical time spent in the pharmacy filling out and signing paper documents. Click here to learn more about EnlivenHealth.

article thumbnail

Future of Pharmacy Podcast: Achieving the Delicate Balance with OR Medication Management

Omnicell

In a manual environment, you'll also see redundant documentation when an anesthesia professional is required to document all the administered medications on paper, then again in the electronic health record. A more reliable, technology-driven approach can support better outcomes and safety in the operating room.

article thumbnail

Why You Need Pharmacy Automation in Your OR

Omnicell

Omnicell has continued to refine medication workflow with the XT Anesthesia Workstation™ , and new functionality helps both parties accomplish this goal. We’ve developed closed-loop functionality that makes it easier for providers to document waste, improving the likelihood of compliance.

article thumbnail

New Breakthrough Devices Program Guidance: Expanding Opportunities for Medical Product Innovations

The FDA Law Blog

Background The Breakthrough Devices Program, established under section 515B of the Federal Food, Drug, and Cosmetic Act (FD&C Act), is a voluntary program for certain medical devices and device-led combination products. By Philip Won & Lisa M. Wysa, see here ) and addiction (e.g., reSET-O, see here , here ).

article thumbnail

(Slightly More) Options for cGMP for Combination Products: FDA Describes Alternative or Streamlined Mechanisms for Compliance

The FDA Law Blog

FDA published a proposed list on June 13, 2018 (83 FR 27609), which we blogged about here. much like an FDA guidance document. Some low-risk devices are exempt from cGMPs except for complaint handling and record keeping requirements, e.g. , a liquid medication dispenser ( 21 C.F.R. 880.6430 ).

FDA 40